What companies are 6589.TWO's competitors?

EirGenix Inc. (6589.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 6589.TWO compare to its peers?

The peer comparison table on this page shows EirGenix Inc. (6589.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 6589.TWO operate in?

EirGenix Inc. (6589.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

6589.TWO (EirGenix Inc.) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

6589.TWO

EirGenix Inc.

TWO·Biotechnology · Healthcare

NT$45.95NT$1.10−2.34%

Market capNT$13.69B·Market closed·Jul 28 5:30 AM UTC

Frequently Asked Questions About 6589.TWO

What companies are 6589.TWO's competitors?: EirGenix Inc. (6589.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 6589.TWO compare to its peers?: The peer comparison table on this page shows EirGenix Inc. (6589.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 6589.TWO operate in?: EirGenix Inc. (6589.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

6589.TWO (EirGenix Inc.) is no longer actively trading.

6589.TWO

EirGenix Inc.

TWO·Biotechnology · Healthcare

NT$45.95NT$1.10−2.34%

Market capNT$13.69B·Market closed·Jul 28 5:30 AM UTC

Peers


4743.TWO	Oneness Biotech Co., Ltd.	NT$47.80	NT$22.9B
6547.TWO	Medigen Vaccine Biologics Corp.	NT$61.90	NT$20.3B
4147.TWO	TaiMed Biologics Inc.	NT$65.60	NT$17.8B
6945.TWO	AP Biosciences Inc	NT$101.50	NT$9.8B
4162.TWO	PharmaEngine, Inc.	NT$60.10	NT$8.6B
4142.TW	Adimmune Corporation	NT$18.00	NT$7.6B
4726.TWO	Mycenax Biotech Inc.	NT$24.50	NT$5.1B
4174.TWO	OBI Pharma, Inc.	NT$26.70	NT$3.5B
6492.TWO	Senhwa Biosciences, Inc.	NT$35.70	NT$3.2B
3164.TW	GenMont Biotech Incorporation	NT$16.10	NT$1.4B

Frequently Asked Questions About 6589.TWO

What companies are 6589.TWO's competitors?: EirGenix Inc. (6589.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 6589.TWO compare to its peers?: The peer comparison table on this page shows EirGenix Inc. (6589.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 6589.TWO operate in?: EirGenix Inc. (6589.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.